{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:49:38Z","timestamp":1757702978368},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.thromres.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:07:21Z","timestamp":1520471241000},"page":"14-17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants"],"prefix":"10.1016","volume":"165","author":[{"given":"Richard","family":"Godin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thromres.2013.07.017","article-title":"Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis","volume":"132","author":"Alotaibi","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.03.004_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2016.09.007","article-title":"Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboembolism","volume":"148","author":"Krause","year":"2016","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2018.03.004_bb0015","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.thromres.2018.03.004_bb0020","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Hokusai","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.thromres.2018.03.004_bb0025","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Investigators","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.thromres.2018.03.004_bb0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Investigators","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.03.004_bb0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/PPA.S104446","article-title":"Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance","volume":"10","author":"Kline","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"11","key":"10.1016\/j.thromres.2018.03.004_bb0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/bjh.14003","article-title":"Heavy menstrual bleeding on rivaroxaban - comparison with apixaban","volume":"176","author":"Myers","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2018.03.004_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93-95","author":"Godin","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2018.03.004_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood.V128.22.140.140","article-title":"Dabigatran is associated with a significantly lower risk of abnormal uterine bleeding than warfarin in female patients of childbearing age with venous thromboembolism","volume":"128","author":"Ferreira","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.03.004_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00404-014-3394-2","article-title":"Conservative management of corpus luteum haemorrhage in patients on anticoagulation: a report of three cases and review of literature","volume":"291","author":"Gupta","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"issue":"8","key":"10.1016\/j.thromres.2018.03.004_bb0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0002-9378(16)33127-1","article-title":"Ovarian hemorrhage due to anticoagulants","volume":"131","author":"Semchyshyn","year":"1978","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.004_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0020-7292(01)00534-3","article-title":"Ruptured corpus luteum cysts and anticoagulant therapy","volume":"76","author":"Jamal","year":"2002","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.004_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/096120339900800614","article-title":"Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases","volume":"8","author":"Cretel","year":"1999","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9378(84)90282-5","article-title":"Ruptured corpus luteum with hemoperitoneum: a study of 173 surgical cases","volume":"149","author":"Hallatt","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0961203310383300","article-title":"Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome","volume":"20","author":"Yamakami","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2018.03.004_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4236\/ojog.2017.75061","article-title":"Menstrual abnormalities and gynaecological problems in women on anticoagulant and antiplatelet therapy: management options","volume":"7","author":"Devabhaktuni","year":"2017","journal-title":"Open Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.thromres.2018.03.004_bb0105","first-page":"1","article-title":"von Willebrand's disease in Sweden","volume":"238","author":"Silwer","year":"1973","journal-title":"Acta Paediatr. Scand. Suppl."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091171","article-title":"Successful conservative management of ruptured ovarian cysts with hemoperitoneum in healthy women","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.thromres.2018.03.004_bb0115","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.1978.03280480062023","article-title":"Corpus luteum hemorrhage. Cause of acute abdominal pain in patients receiving anticoagulant therapy","volume":"239","author":"Waxman","year":"1978","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.thromres.2018.03.004_bb0120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1991.tb13514.x","article-title":"Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies","volume":"98","author":"Greer","year":"1991","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2516.2005.01108.x","article-title":"More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders","volume":"11","author":"James","year":"2005","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00004728-199307000-00020","article-title":"Hemorrhagic ovarian cysts in patients on anticoagulation therapy: CT findings","volume":"17","author":"Wilbur","year":"1993","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2018.03.004_bb0135","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.thromres.2018.03.004_bb0140","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jacc.2017.03.605","article-title":"Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves","volume":"69","author":"Steinberg","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.thromres.2018.03.004_bb0145","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1016\/j.jacc.2017.09.1138","article-title":"The anticoagulation conundrum of mechanical heart valves in pregnancy: should DOACs Be Considered?","volume":"70","author":"Godin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jocn.2006.03.031","article-title":"Neurological sequelae of intrauterine warfarin exposure","volume":"14","author":"Raghav","year":"2007","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.004_bb0155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0000000000000277","article-title":"Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta","volume":"123","author":"Bapat","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.thromres.2018.03.004_bb0160","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/jth.13353","article-title":"Examining the transplacental passage of apixaban using the dually perfused human placenta","volume":"14","author":"Bapat","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0165","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ajog.2015.06.065","article-title":"Rivaroxaban transfer across the dually perfused isolated human placental cotyledon","volume":"213","author":"Bapat","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00392-015-0893-5","article-title":"Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre","volume":"105","author":"Hoeltzenbein","year":"2016","journal-title":"Clin. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.004_bb0175","first-page":"313","article-title":"Pregnancy in patients with heart valve prosthesis. Retrospective study apropos of 40 pregnancies","volume":"43","author":"Thomas","year":"1994","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0180","first-page":"14","article-title":"Blood loss at the time of surgical abortion up to 14\u202fweeks in anticoagulated patients: a case series","volume":"96","author":"Kaneshiro","year":"2017","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13625180400020952","article-title":"Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum","volume":"10","author":"Sonmezer","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2018.03.004_bb0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2516.2011.02558.x","article-title":"Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres","volume":"17","author":"Byams","year":"2011","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2516.1998.00143.x","article-title":"Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease","volume":"4","author":"Gomez","year":"1998","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000141782","article-title":"Control of ovulation-induced hemoperitoneum by oral contraceptives in a patient with congenital hypoprothrombinemia and in another with congenital factor V deficiency","volume":"119","author":"Girolami","year":"2008","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2516.1998.01772.x","article-title":"Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive","volume":"4","author":"Ghosh","year":"1998","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.thromres.2018.03.004_bb0210","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2015.03.001","article-title":"Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial","volume":"91","author":"Seidman","year":"2015","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.thromres.2018.03.004_bb0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2018.03.004_bb0220","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijgo.2015.10.028","article-title":"Rationale for eliminating the hormone-free interval in modern oral contraceptives","volume":"134","author":"London","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0230","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmig.2009.04.018","article-title":"The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy","volume":"16","author":"Vilos","year":"2009","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2009.02.007","article-title":"The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement","volume":"80","author":"Kilic","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.004_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2013.06.012","article-title":"Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and\/or a history of thrombosis","volume":"89","author":"Braga","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2018.03.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.thromres.2018.03.004_bb0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.004_bb0260","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00404-009-0997-0","article-title":"Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation","volume":"280","author":"Ott","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.thromres.2018.03.004_bb0265","series-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2015"},{"issue":"4","key":"10.1016\/j.thromres.2018.03.004_bb0270","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"Baglin","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.03.004_bb0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.03.013","article-title":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism: expert opinion versus current practice: combined results of a systematic review, expert panel opinion and an international survey","volume":"153","author":"Klok","year":"2017","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T23:32:03Z","timestamp":1603927923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818302706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":55,"alternative-id":["S0049384818302706"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An opinion on the benefits of concomitant oral contraceptive therapy in premenopausal women treated with oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}